<DOC>
	<DOC>NCT00683982</DOC>
	<brief_summary>Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be clinically important in time of hospitalization and reduction of duration of diarrhea secondary to rotavirus?</brief_summary>
	<brief_title>Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus</brief_title>
	<detailed_description>Nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing duration time of diarrhea in comparison to placebo in previous studies. In the current study, based in those results, we design a randomized single-blind controlled trial, in order to asses the effectiveness of nitazoxanide and probiotics in comparison with a control group</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Positive stool sample for rotavirus test Severe malnourishment Severe dehydration History of diarrhea more than 3 days previous hospitalization Use of antibiotics, probiotics or nitazoxanide 3 weeks before admission Systemic infections Severe chronic disease Mixed enteric infections besides rotavirus</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>nitazoxanide</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Rotavirus</keyword>
	<keyword>Children</keyword>
</DOC>